Detailed answers about VANTAGE CLINICAL RESEARCH SERVICES LIMITED, including incorporation, status, business activity, and accounts information.
When was VANTAGE CLINICAL RESEARCH SERVICES LIMITED founded?
VANTAGE CLINICAL RESEARCH SERVICES LIMITED was officially incorporated on 14 October 2026 and is registered under company number 17521051. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is VANTAGE CLINICAL RESEARCH SERVICES LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of VANTAGE CLINICAL RESEARCH SERVICES LIMITED?
VANTAGE CLINICAL RESEARCH SERVICES LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does VANTAGE CLINICAL RESEARCH SERVICES LIMITED do?
VANTAGE CLINICAL RESEARCH SERVICES LIMITED operates in the following sector: 72110 - Research and experimental development on biotechnology. This provides insight into the company's primary business activity and industry focus.
What is VANTAGE CLINICAL RESEARCH SERVICES LIMITED's registered address?
The registered office address of VANTAGE CLINICAL RESEARCH SERVICES LIMITED is The American Barns Banbury Road, Cv35 0ae, Warwick, Warwickshire, United Kingdom, CV35 0AE. This is the official address filed with Companies House for legal and statutory correspondence.
Is VANTAGE CLINICAL RESEARCH SERVICES LIMITED financially stable?
Financial accounts for VANTAGE CLINICAL RESEARCH SERVICES LIMITED are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.